Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kith Pradhan

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2021
Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancerRitesh K Aggarwal, Rebecca A Luchtel, Venkata Machha, et al.
Leukemia & Lymphoma|July 9, 2019
HIV portends a poor prognosis in myelodysplastic syndromesJustin D Kaner, Santiago Thibaud, Sakshi Jasra, et al.
Neuroimage|August 19, 2008
Fast uptake and long-lasting binding of methamphetamine in the human brain: comparison with cocaineJoanna S Fowler, Nora D Volkow, Jean Logan, et al.
Cancer Discovery|May 3, 2020
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital SystemVikas Mehta, Sanjay Goel, Rafi Kabarriti, et al.
Cell Reports|December 14, 2022
Splicing factor deficits render hematopoietic stem and progenitor cells sensitive to STAT3 inhibitionKathryn S Potts, Rosannah C Cameron, Amina Metidji, et al.
JCI Insight|April 14, 2017
Efficacy of ALK5 inhibition in myelofibrosisLanzhu Yue, Matthias Bartenstein, Wanke Zhao, et al.
Nature Cell Biology|April 24, 2019
U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignanciesMolly A Smith, Gaurav S Choudhary, Andrea Pellagatti, et al.
JAMA Oncology|May 1, 2018
Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center DisasterOla Landgren, Rachel Zeig-Owens, Orsolya Giricz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic SyndromesValeria Santini, David Valcárcel, Uwe Platzbecker, et al.
Cancer Discovery|February 17, 2022
The Genomics of Colorectal Cancer in Populations with African and European AncestryParvathi A Myer, Jessica K Lee, Russell W Madison, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2021
Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancerRitesh K Aggarwal, Rebecca A Luchtel, Venkata Machha, et al.
Leukemia & Lymphoma|July 9, 2019
HIV portends a poor prognosis in myelodysplastic syndromesJustin D Kaner, Santiago Thibaud, Sakshi Jasra, et al.
Neuroimage|August 19, 2008
Fast uptake and long-lasting binding of methamphetamine in the human brain: comparison with cocaineJoanna S Fowler, Nora D Volkow, Jean Logan, et al.
Cancer Discovery|May 3, 2020
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital SystemVikas Mehta, Sanjay Goel, Rafi Kabarriti, et al.
Cell Reports|December 14, 2022
Splicing factor deficits render hematopoietic stem and progenitor cells sensitive to STAT3 inhibitionKathryn S Potts, Rosannah C Cameron, Amina Metidji, et al.
JCI Insight|April 14, 2017
Efficacy of ALK5 inhibition in myelofibrosisLanzhu Yue, Matthias Bartenstein, Wanke Zhao, et al.
Nature Cell Biology|April 24, 2019
U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignanciesMolly A Smith, Gaurav S Choudhary, Andrea Pellagatti, et al.
JAMA Oncology|May 1, 2018
Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center DisasterOla Landgren, Rachel Zeig-Owens, Orsolya Giricz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic SyndromesValeria Santini, David Valcárcel, Uwe Platzbecker, et al.
Cancer Discovery|February 17, 2022
The Genomics of Colorectal Cancer in Populations with African and European AncestryParvathi A Myer, Jessica K Lee, Russell W Madison, et al.
Pageof 9